Literature DB >> 2423778

Human mast cells use conservation and condensation mechanisms during recovery from degranulation. In vitro studies with mast cells purified from human lungs.

A M Dvorak, R P Schleimer, E S Schulman, L M Lichtenstein.   

Abstract

Human lung mast cells were isolated from enzymatically digested lung fragments and partially purified by countercurrent centrifugation elutriation before stimulation with anti-immunoglobulin E (IgE). Stimulated cells and control preparations were fixed for electron microscopy, and replicate samples were obtained for histamine determinations at early times (0 to 20 minutes) after stimulation. Other samples of stimulated and control cells were placed in culture media and recovered for electron microscopic studies after variable times spanning 3 to 48 hours. Two complete kinetic studies of release and recovery were studied. The starting purity of mast cells was 59% and 66% and the maximal histamine release at 20 minutes poststimulus was 72% and 45%, respectively, for these two studies. Mast cells underwent granule swelling and fusion with elongation and enlargement of granule chains to form degranulation channels which permeated the cytoplasm. Granule patterns became swollen and altered within channels which ultimately opened to the exterior through multiple pores. Altered granule matrix disappeared from many open channels. Residual granules that did not participate in this process did not swell and fuse their membranes. Early recovery events included conservation of granule containers (membranes) and contents. Degranulation channels became centrally located and developed granule-shaped domains. Strings of vesicles, lipid bodies, filament-rich cytoplasmic invaginations, and membranes were found at constriction points in resolving channel-granules. As resolution of channel-granules occurred, condensation of channel-granule contents also took place. Progressively dense content developed in granule containers within which focal areas of crystallization and content organization were noted. Eventually, numerous granules with a crystal pattern were found in recovering mast cells. Other granule patterns (scrolls, particles, and mixed) were present but in smaller numbers. Human lung mast cells have the ability to repackage contents in the same container after stimulation with anti-IgE. Although this was a prominent recovery pattern in the earlier periods examined, this did not constitute the only recovery pattern. Overlap with different events at later times was noted. These are currently being further investigated. The biochemical composition and physiologic function(s) of human mast cell granule membranes are unknown. Our findings suggest that certain analogies to other secretory granule membranes may exist. Clearly, containers can be reused, nearly in toto.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423778

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

1.  Ultrastructural cytochemical, immunocytochemical and in situ hybridization methods with polyuridine probes detect mRNA in human mast cell granules.

Authors:  A M Dvorak; E S Morgan
Journal:  Histochem J       Date:  2000-07

2.  The ultrastructure of mast cells in the uterus throughout the normal menstrual cycle and the postmenopause.

Authors:  L Drudy; B L Sheppard; J Bonnar
Journal:  J Anat       Date:  1991-04       Impact factor: 2.610

3.  Connective tissue mast cells exhibit time-dependent degranulation heterogeneity.

Authors:  M S Kaminer; G F Murphy; B Zweiman; R M Lavker
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

4.  Human lung-derived mature mast cells cultured alone or with mouse 3T3 fibroblasts maintain an ultrastructural phenotype different from that of human mast cells that develop from human cord blood cells cultured with 3T3 fibroblasts.

Authors:  A M Dvorak; T Furitsu; P Estrella; T Ishizaka
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

5.  Searching for tryptase in the RBL-2H3 mast cell model: Preparation for comparative mast cell toxicology studies with zebrafish.

Authors:  Juyoung K Shim; Rachel H Kennedy; Lisa M Weatherly; Andrew V Abovian; Hina N Hashmi; Atefeh Rajaei; Julie A Gosse
Journal:  J Appl Toxicol       Date:  2018-10-30       Impact factor: 3.446

6.  Mast cell activation in the skin of Plasmodium falciparum malaria patients.

Authors:  Panop Wilainam; Rungrat Nintasen; Parnpen Viriyavejakul
Journal:  Malar J       Date:  2015-02-07       Impact factor: 2.979

7.  Intercellular interactions between mast cells and stromal fibroblasts obtained from canine cutaneous mast cell tumours.

Authors:  Lidia H Pulz; Yonara G Cordeiro; Greice C Huete; Karine G Cadrobbi; Arina L Rochetti; Pedro L P Xavier; Adriana Tomoko Nishiya; Silvio Henrique de Freitas; Heidge Fukumasu; Ricardo F Strefezzi
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

8.  Allergic rhinoconjunctivitis: the role of histamine.

Authors:  M Andersson; L Greiff; C Svensson
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

9.  Immunophenotypic and Ultrastructural Analysis of Mast Cells in Hermansky-Pudlak Syndrome Type-1: A Possible Connection to Pulmonary Fibrosis.

Authors:  Arnold S Kirshenbaum; Glenn Cruse; Avanti Desai; Geethani Bandara; Maarten Leerkes; Chyi-Chia R Lee; Elizabeth R Fischer; Kevin J O'Brien; Bernadette R Gochuico; Kelly Stone; William A Gahl; Dean D Metcalfe
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

Review 10.  Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts.

Authors:  Peter Valent; Cem Akin; Karin Hartmann; Gunnar Nilsson; Andreas Reiter; Olivier Hermine; Karl Sotlar; Wolfgang R Sperr; Luis Escribano; Tracy I George; Hanneke C Kluin-Nelemans; Celalettin Ustun; Massimo Triggiani; Knut Brockow; Jason Gotlib; Alberto Orfao; Petri T Kovanen; Emir Hadzijusufovic; Irina Sadovnik; Hans-Peter Horny; Michel Arock; Lawrence B Schwartz; K Frank Austen; Dean D Metcalfe; Stephen J Galli
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.